Status:
TERMINATED
Neurocognitive Effects of Bilateral STN Versus GPi DBS in Parkinson's Disease Patients With MCI
Lead Sponsor:
St. Joseph's Hospital and Medical Center, Phoenix
Conditions:
Parkinson's Disease
Mild Cognitive Impairment
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Purpose: This is a prospective single-center, randomized, patient and evaluator-blind clinical trial to compare the neurocognitive outcomes of globus pallidus interna (GPi) versus subthalamic nucleus ...
Detailed Description
Deep brain stimulation (DBS) of the globus pallidus interna (GPi) or subthalamic nucleus (STN) has been accepted as the surgical treatment of choice for patients with advanced Parkinson's Disease (PD)...
Eligibility Criteria
Inclusion
- clinical diagnosis of idiopathic Parkinson's disease
- deemed an appropriate candidate for DBS surgery
- Montreal Cognitive Assessment (MoCA) score \< 25
- Neuropsychological testing with the diagnosis of Mild Cognitive Impairment
Exclusion
- no diagnosis of Parkinson's disease
- not appropriate for DBS surgery
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT01870518
Start Date
April 1 2013
End Date
February 1 2016
Last Update
February 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barrow Neurological Institute / St. Joseph's Hospital & Medical Center
Phoenix, Arizona, United States, 85013